Penile Constriction Devices as Non-Pharmacological Adjuncts to Phosphodiesterase-5 Inhibitors in Refractory Erectile Dysfunction: A Mechanistic and Clinical Review

Background: Oral phosphodiesterase type 5 (PDE5) inhibitors are established first-line pharmacotherapies for erectile dysfunction (ED), yet approximately 30% to 35% of patients fail to achieve satisfactory rigidity. Objective: To review the physiological rationale, clinical efficacy evidence, and safety profile of external penile constriction devices (PCDs)—applied alone or banded with vacuum erection therapy—as mechanical adjuncts to salvage PDE5 inhibitor non-responders, and to propose a structured clinical escalation protocol. Results: Combination therapy leverages complementary physiological mechanisms: PDE5 inhibitors amplify NO-mediated cavernosal smooth muscle relaxation, whereas external constriction rings restrict venous drainage through Buck's fascia. Conclusions: External penile constriction devices represent an underutilized, non-invasive, low-cost salvage modality prior to initiating invasive therapies. Conflict of Interest: Dr. Mohd Amiruddin Mohd Nor is the clinical founder and medical director of SuamiSihat Clinic and has commercial involvement with the Dr MIT Ring constriction device.

Authors

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-17
DOI
https://doi.org/10.5281/zenodo.24298542
Primary Topic
Sexual function and dysfunction studies
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

Penile Constriction Devices as Non-Pharmacological Adjuncts to Phosphodiesterase-5 Inhibitors in Refractory Erectile Dysfunction: A Mechanistic and Clinical Review

Mohd Amiruddin Mohd Nor
1 links
Zenodo (CERN European Organization for Nuclear Research)
Sexual function and dysfunction studies
preprint

Penile Constriction Devices as Non-Pharmacological Adjuncts to Phosphodiesterase-5 Inhibitors in Refractory Erectile Dysfunction: A Mechanistic and Clinical Review

Mohd Amiruddin Mohd Nor
preprint en

Abstract

Background: Oral phosphodiesterase type 5 (PDE5) inhibitors are established first-line pharmacotherapies for erectile dysfunction (ED), yet approximately 30% to 35% of patients fail to achieve satisfactory rigidity. Objective: To review the physiological rationale, clinical efficacy evidence, and safety profile of external penile constriction devices (PCDs)—applied alone or banded with vacuum erection therapy—as mechanical adjuncts to salvage PDE5 inhibitor non-responders, and to propose a structured clinical escalation protocol. Results: Combination therapy leverages complementary physiological mechanisms: PDE5 inhibitors amplify NO-mediated cavernosal smooth muscle relaxation, whereas external constriction rings restrict venous drainage through Buck's fascia. Conclusions: External penile constriction devices represent an underutilized, non-invasive, low-cost salvage modality prior to initiating invasive therapies. Conflict of Interest: Dr. Mohd Amiruddin Mohd Nor is the clinical founder and medical director of SuamiSihat Clinic and has commercial involvement with the Dr MIT Ring constriction device.

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Sexual function and dysfunction studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon